Glenmark Investigational Site 17 — Fullerton, California

Glenmark Investigational Site 17 is a clinical research site located in Fullerton, California, United States 92835.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Glenmark Investigational Site 17 has participated in 1 clinical trials.

Therapeutic areas: Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD).

Sponsors: Glenmark Specialty S.A..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Glenmark Investigational Site 17?

Glenmark Investigational Site 17 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Glenmark Investigational Site 17 conducted?

Glenmark Investigational Site 17 has 1 clinical trials on record. Their work covers Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD).

Is Glenmark Investigational Site 17 accredited by Crixeo Health?

Glenmark Investigational Site 17 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Glenmark Investigational Site 17?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.